CMR phenotypes and clinical outcomes in NYHA class I versus II-IV hypertrophic cardiomyopathy: identifying high-risk asymptomatic patients
1 September 2024 (14:00 - 14:50)
Organised by: 
About the speaker
Libin Cardiovascular Institute Of Alberta, Calgary (Canada)
6 More presentations in this session
Doctor H. Lee (Seoul, KR)
Doctor M. Golino (Jacksonville, US)
Doctor E. Hancioglu (Hatay, TR)
Doctor M. Marques Antunes (Lisboa, PT)
Doctor K. Fragkiadakis (Heraklion, GR)
Access the full session
The Event
ESC Congress 2024
1 September 2024
14:00 CET
You may be interested in
Congress Presentation
